Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  Cancer Health Disparities Conference 2009
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 37, 3257-3265, September 1, 1977]
© 1977 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Driedger, P. E.
Right arrow Articles by Blumberg, P. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Driedger, P. E.
Right arrow Articles by Blumberg, P. M.

The Effect of Phorbol Diesters on Chicken Embryo Fibroblasts1

Paul E. Driedger2 and Peter M. Blumberg

Department of Pharmacology, Harvard Medical School, Boston, Massachusetts 02115

The tumor promoter phorbol myristate acetate (PMA) at concentrations of 1 to 30 ng/ml (1.5 to 45 x 10–9 M) had dramatic effects on chicken embryo fibroblasts (CEF). Cell morphology, size, growth, and deoxyglucose transport were among the altered properties. Of the morphological changes, the typical parallel orientation of cells on the plate was lacking for CEF grown to confluence in the presence of PMA (30 ng/ml). In sparse as well as dense cultures, PMA caused the cells to appear thinner and more elongated, with prominent processes; initial changes were discernible within 3 hr. Cell volume was decreased by PMA over the course of 2 to 3 days. The plateau value for cell volume was 62% of that of the control cultures. The exponential growth rate of CEF cultures in PMA at 50 ng/ml was not significantly altered. However, as growth rates leveled off after 3 days, cells in PMA eventually reached a 1.8-fold higher density than did those in control cultures. Resting CEF were stimulated to divide by PMA; cell number increased by 80% within 24 hr of PMA addition. The half-maximally effective dose of PMA for mitogenic stimulation was 2.3 ng/ml. PMA showed a similar half-maximally effective dose for stimulation of [G3H]-2-deoxy-D-glucose uptake. Uptake reached a peak quickly, 4 to 6 hr after PMA addition, and attained a level 90% of that induced by addition of chicken serum (10%, final concentration). Stimulation of [G-3H]-2-deoxy-D-glucose uptake by other phorbol derivatives was investigated. The half-maximally effective doses for phorbol 12,13-dibenzoate, 4-O-methyl phorbol 12-myristate 13-acetate, phorbol 12,13-diacetate, and phorbol 12,13,20-triacetate occurred at 5.7, 240, 405, and 6400 ng/ml, respectively, whereas phorbol itself was completely inactive at concentrations up to 20,000 ng/ml. The results lend additional support to a model for the mechanism of action of tumor promoters.

1 This work was supported by Grant CA18294 from the National Cancer Institute. A preliminary report on a portion of the work has appeared previously (5).

2 Predoctoral Fellow of the National Science Foundation.

Received 3/10/77. Accepted 5/27/77.




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
S. H. Choi, G. Czifra, N. Kedei, N. E. Lewin, J. Lazar, Y. Pu, V. E. Marquez, and P. M. Blumberg
Characterization of the Interaction of Phorbol Esters with the C1 Domain of MRCK (Myotonic Dystrophy Kinase-related Cdc42 Binding Kinase) {alpha}/{beta}
J. Biol. Chem., April 18, 2008; 283(16): 10543 - 10549.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
R. B. Robey, J. Ma, and A. V. P. Santos
Regulation of mesangial cell hexokinase activity by PKC and the classic MAPK pathway
Am J Physiol Renal Physiol, November 1, 1999; 277(5): F742 - F749.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Joaquin, C. Salvado, B. Bellosillo, A. J. Lange, J. Gil, and A. Tauler
Effect of Growth Factors on the Expression of 6-Phosphofructo2-kinase/Fructose-2,6-bisphosphatase in Rat-1 Fibroblasts
J. Biol. Chem., January 31, 1997; 272(5): 2846 - 2851.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Goodnight, H. Mischak, W. Kolch, and J. F. Mushinski
Immunocytochemical Localization of Eight Protein Kinase C Isozymes Overexpressed in NIH 3T3 Fibroblasts
J. Biol. Chem., April 28, 1995; 270(17): 9991 - 10001.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
J. Flier, M. Mueckler, P Usher, and H. Lodish
Elevated levels of glucose transport and transporter messenger RNA are induced by ras or src oncogenes
Science, March 20, 1987; 235(4795): 1492 - 1495.
[Abstract] [PDF]


Home page
ScienceHome page
T Hirakawa, T Kakunaga, H Fujiki, and T Sugimura
A new tumor-promoting agent, dihydroteleocidin B, markedly enhances chemically induced malignant cell transformation
Science, April 30, 1982; 216(4545): 527 - 529.
[Abstract] [PDF]


Home page
ScienceHome page
A. Goldberg, K. Delclos, and P. Blumberg
Phorbol ester action is independent of viral and cellular src kinase levels
Science, April 11, 1980; 208(4440): 191 - 193.
[Abstract] [PDF]


Home page
ScienceHome page
L. Lee and I. Weinstein
Tumor-promoting phorbol esters inhibit binding of epidermal growth factor to cellular receptors
Science, October 20, 1978; 202(4365): 313 - 315.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1977 by the American Association for Cancer Research.